ArticleTherapeutic advances in medical oncology2025

Nab-paclitaxel-based chemotherapy with or without anti-PD-(L)1 immunotherapy as a second-line treatment for advanced biliary tract cancer: a real-world retrospective study.

Nan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.